Cargando…

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

AIMS: Endothelial activation, macrophage infiltration, and foam cell formation are pivotal steps in atherogenesis. Our aim in this study was to analyse the role of SIRT1, a class III deacetylase with important metabolic functions, in plaque macrophages and atherogenesis. METHODS AND RESULTS: Using p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Sokrates, Lohmann, Christine, Schäfer, Nicola, Hofmann, Janin, Rohrer, Lucia, Besler, Christian, Rothgiesser, Karin M., Becher, Burkhard, Hottiger, Michael O., Borén, Jan, McBurney, Michael W., Landmesser, Ulf, Lüscher, Thomas F., Matter, Christian M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938465/
https://www.ncbi.nlm.nih.gov/pubmed/20418343
http://dx.doi.org/10.1093/eurheartj/ehq107
_version_ 1782186624354877440
author Stein, Sokrates
Lohmann, Christine
Schäfer, Nicola
Hofmann, Janin
Rohrer, Lucia
Besler, Christian
Rothgiesser, Karin M.
Becher, Burkhard
Hottiger, Michael O.
Borén, Jan
McBurney, Michael W.
Landmesser, Ulf
Lüscher, Thomas F.
Matter, Christian M.
author_facet Stein, Sokrates
Lohmann, Christine
Schäfer, Nicola
Hofmann, Janin
Rohrer, Lucia
Besler, Christian
Rothgiesser, Karin M.
Becher, Burkhard
Hottiger, Michael O.
Borén, Jan
McBurney, Michael W.
Landmesser, Ulf
Lüscher, Thomas F.
Matter, Christian M.
author_sort Stein, Sokrates
collection PubMed
description AIMS: Endothelial activation, macrophage infiltration, and foam cell formation are pivotal steps in atherogenesis. Our aim in this study was to analyse the role of SIRT1, a class III deacetylase with important metabolic functions, in plaque macrophages and atherogenesis. METHODS AND RESULTS: Using partial SIRT1 deletion in atherosclerotic mice, we demonstrate that SIRT1 protects against atherosclerosis by reducing macrophage foam cell formation. Peritoneal macrophages from heterozygous SIRT1 mice accumulate more oxidized low-density lipoprotein (oxLDL), thereby promoting foam cell formation. Bone marrow-restricted SIRT1 deletion confirmed that SIRT1 function in macrophages is sufficient to decrease atherogenesis. Moreover, we show that SIRT1 reduces the uptake of oxLDL by diminishing the expression of lectin-like oxLDL receptor-1 (Lox-1) via suppression of the NF-κB signalling pathway. CONCLUSION: Our findings demonstrate protective effects of SIRT1 in atherogenesis and suggest pharmacological SIRT1 activation as a novel anti-atherosclerotic strategy by reducing macrophage foam cell formation.
format Text
id pubmed-2938465
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-29384652010-09-15 SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis Stein, Sokrates Lohmann, Christine Schäfer, Nicola Hofmann, Janin Rohrer, Lucia Besler, Christian Rothgiesser, Karin M. Becher, Burkhard Hottiger, Michael O. Borén, Jan McBurney, Michael W. Landmesser, Ulf Lüscher, Thomas F. Matter, Christian M. Eur Heart J Basic Science AIMS: Endothelial activation, macrophage infiltration, and foam cell formation are pivotal steps in atherogenesis. Our aim in this study was to analyse the role of SIRT1, a class III deacetylase with important metabolic functions, in plaque macrophages and atherogenesis. METHODS AND RESULTS: Using partial SIRT1 deletion in atherosclerotic mice, we demonstrate that SIRT1 protects against atherosclerosis by reducing macrophage foam cell formation. Peritoneal macrophages from heterozygous SIRT1 mice accumulate more oxidized low-density lipoprotein (oxLDL), thereby promoting foam cell formation. Bone marrow-restricted SIRT1 deletion confirmed that SIRT1 function in macrophages is sufficient to decrease atherogenesis. Moreover, we show that SIRT1 reduces the uptake of oxLDL by diminishing the expression of lectin-like oxLDL receptor-1 (Lox-1) via suppression of the NF-κB signalling pathway. CONCLUSION: Our findings demonstrate protective effects of SIRT1 in atherogenesis and suggest pharmacological SIRT1 activation as a novel anti-atherosclerotic strategy by reducing macrophage foam cell formation. Oxford University Press 2010-09 2010-04-23 /pmc/articles/PMC2938465/ /pubmed/20418343 http://dx.doi.org/10.1093/eurheartj/ehq107 Text en Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/2.0/uk/ The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
spellingShingle Basic Science
Stein, Sokrates
Lohmann, Christine
Schäfer, Nicola
Hofmann, Janin
Rohrer, Lucia
Besler, Christian
Rothgiesser, Karin M.
Becher, Burkhard
Hottiger, Michael O.
Borén, Jan
McBurney, Michael W.
Landmesser, Ulf
Lüscher, Thomas F.
Matter, Christian M.
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
title SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
title_full SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
title_fullStr SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
title_full_unstemmed SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
title_short SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
title_sort sirt1 decreases lox-1-mediated foam cell formation in atherogenesis
topic Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938465/
https://www.ncbi.nlm.nih.gov/pubmed/20418343
http://dx.doi.org/10.1093/eurheartj/ehq107
work_keys_str_mv AT steinsokrates sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT lohmannchristine sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT schafernicola sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT hofmannjanin sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT rohrerlucia sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT beslerchristian sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT rothgiesserkarinm sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT becherburkhard sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT hottigermichaelo sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT borenjan sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT mcburneymichaelw sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT landmesserulf sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT luscherthomasf sirt1decreaseslox1mediatedfoamcellformationinatherogenesis
AT matterchristianm sirt1decreaseslox1mediatedfoamcellformationinatherogenesis